Moderate riskFDA DrugClass II

Major Pharmaceuticals Methylergonovine Maleate 0.2 mg tablets recalled for subpotency

MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.

From the FDA notice · Read the official notice ↗ · All The Harvard Drug recalls

What to do

  1. If you have a prescription for this medication, contact your pharmacy or doctor immediately.
  2. Do not stop taking your medication without speaking to your doctor.
  3. Check the lot number on your bottle against the recall list: N02327 (expires 09/2026), N02740 (expires 12/2026), or N03069 (expires 08/2027).

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
790 Cartons.
Illnesses reported
None reported
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Classification
Class II
Recall number
D-0609-2026

In the FDA's words

Description
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10. Subpotent Drug Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027. Distribution: U.S. Nationwide. Affected quantity: 790 Cartons.
Hazard
Subpotent Drug

Related topics

PotencyDrugsSold nationwideMore from FDA Drug